Sun Summit Minerals (TSXV:SMN) Closes $11.5 Million Private Placement

Vancouver, British Columbia — December 23, 2025 — Leads & Copy — Sun Summit Minerals Corp. has completed a non-brokered private placement, raising $11.5 million.

The placement involved the issuance of 67,857,143 charity flow-through common shares at $0.14 each, and 20,000,000 non-flow-through common shares at $0.10 each, according to the company.

The company intends to allocate the proceeds to explore its JD, Theory, and Buck properties, as well as any other Canadian properties it may acquire. Part of the funds will also be used for general working capital.

Sun Summit reported it will use an amount equal to the gross proceeds received by the Company from the sale of the Charity FT Shares to incur eligible “Canadian exploration expenses” that will qualify as “flow-through mining expenditures” as such terms are defined in the Tax Act.

The company also paid $303,380 in finder’s fees and granted 2,944,400 non-transferable finder warrants. Each warrant allows the holder to purchase one common share at $0.14 until December 23, 2027.

The private placement is awaiting final approval from the TSX Venture Exchange. Securities issued are subject to a hold period expiring on April 24, 2025, as per securities laws.

Sun Summit also announced the granting of 9,000,000 stock options to employees, directors, and advisors, pending TSXV approval. Each option allows the holder to acquire a common share at $0.15 until December 23, 2030.

Sun Summit Minerals is focused on discovering and developing district-scale gold and copper assets in British Columbia, including the JD, Theory, and Buck Projects.

Niel Marotta is the Chief Executive Officer & Director of Sun Summit.

Matthew Benedetto of Simone Capital can be contacted at mbenedetto@simonecapital.ca or 416-817-1226 for further information.

Source: Sun Summit Minerals

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.